Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Jun-Jie Zhang, Danni Colledge, Andrea Jurado, Ning Sun, Hu Zhang, Kathy Jackson, Vitina Sozzi, Xin Li, Nicholas S. Eyre, Michael R. Beard, Radhakrishnan Iyer, Nezam Afdhal, Haitao Guo
Inarigivir exhibits RIG-I-independent antiviral activity against HBV DNA replication in vitro by inhibiting viral polymerase activity. // Biochimica et Biophysica Acta: General Subjects. – URL: https://www.sciencedirect.com/science/article/pii/S0166354226002317?dgcid=rss_sd_all
Inarigivir exhibits RIG-I-independent antiviral activity against HBV DNA replication in vitro by inhibiting viral polymerase activity. Biochimica et Biophysica Acta: General Subjects. https://www.sciencedirect.com/science/article/pii/S0166354226002317?dgcid=rss_sd_all
“Inarigivir exhibits RIG-I-independent antiviral activity against HBV DNA replication in vitro by inhibiting viral polymerase activity.” Biochimica et Biophysica Acta: General Subjects.
@article{article10972,
title = {Inarigivir exhibits RIG-I-independent antiviral activity against HBV DNA replication in vitro by inhibiting viral polymerase activity},
journal = {Biochimica et Biophysica Acta: General Subjects},
url = {https://www.sciencedirect.com/science/article/pii/S0166354226002317?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Sneha Singh, Arijit Vijey Jeyachandran, Maria Daskou, Anne Zaiss, Henry Kolge, Robert E. Wright, Anita Singhal, Anna Bonazzi, Robert Damoiseaux,...